Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/17/1998WO1998056380A1 Method to reverse mydriasis
12/17/1998WO1998056379A1 Compositions and methods for treating glaucoma
12/17/1998WO1998056378A1 Novel niddm regimen
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998WO1998056375A1 Tazarotene and uvb phototherapy treatment for psoriasis
12/17/1998WO1998056373A1 Isoflavonoids for treatment and prevention of aging skin and wrinkles
12/17/1998WO1998056371A1 Use of cis-6-hexadecenoic acid for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin
12/17/1998WO1998056370A2 Therapeutic nanospheres
12/17/1998WO1998056369A1 A pharmaceutical composition for lowering glucose level in blood
12/17/1998WO1998056368A1 Superiority of formulations containing coenzyme q10 in coconut oil
12/17/1998WO1998056365A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
12/17/1998WO1998056364A1 IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
12/17/1998WO1998056360A2 Film-coated tablet for improved upper gastrointestinal tract safety
12/17/1998WO1998056358A1 Rapamycin formulations for oral administration
12/17/1998WO1998056357A1 A controlled release formulation for poorly soluble basic drugs
12/17/1998WO1998056356A1 Therapeutically active compositions
12/17/1998WO1998056355A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent
12/17/1998WO1998056351A1 Powder compositions of unilamellar liposomes
12/17/1998WO1998056325A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
12/17/1998WO1998056323A1 Device and method for treatment of dysmenorrhea
12/17/1998WO1998056250A1 Method for reducing side effects
12/17/1998WO1998056249A1 Method for enhancing the activity of glaucoma drugs
12/17/1998WO1998043649A3 Age production inhibitory composition comprising a maillard reaction inhibitor and vitamin b¿6?
12/17/1998WO1998043617A3 Nutritional composition for improvements in cell energetics
12/17/1998WO1998042708A3 Pharmaceutically active tricyclic amines
12/17/1998WO1998042322A3 Antitussive compositions
12/17/1998WO1998040069A3 Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
12/17/1998WO1998038983A3 Swallow tablet comprising paracetamol
12/17/1998DE19826781A1 Pentaerythritol derivatives
12/17/1998DE19725450A1 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel 4-haloalkyl-3-heterocyclylpyridine and 4-haloalkyl-5-heterocyclylpyrimidine, processes for their preparation, compositions containing them and their use as pesticides
12/17/1998DE19725391A1 Verfahren zur Herstellung von Arzneimittel, enthaltend HMG-CoA-Reduktase-Inhibitoren A process for the production of medicaments comprising HMG-CoA reductase inhibitors
12/17/1998DE19724980A1 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted 3,4-dihydro-thieno [2,3-d] pyrimidine derivatives, their preparation and use
12/17/1998DE19724979A1 3-substituierte Pyrido [3,4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted pyrido [3,4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
12/17/1998DE19724622A1 Verwendung von cis-6-Hexadecensäure zur Behandlung von Psoriasis, Allergien und Autoimmunerkrankungen Using cis-6-hexadecenoic acid for the treatment of psoriasis, allergies and autoimmune diseases
12/17/1998CA2455954A1 4-phenylpiperidine compounds
12/17/1998CA2303268A1 Therapeutic nanospheres
12/17/1998CA2295704A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998CA2295176A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
12/17/1998CA2295013A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent
12/17/1998CA2294062A1 Isoflavonoids for treatment and prevention of aging skin and wrinkles
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293816A1 3-substituted 3,4 dihydro-thieno[2, 3-d]pyrimidine derivatives and production and use of the same
12/17/1998CA2293733A1 Mycardium-and skeletal muscle-specific nucleic acid, its preparation and use
12/17/1998CA2293683A1 Anthelmintic compositions
12/17/1998CA2293582A1 Prevention of ovarian cancer by administration of a vitamin d compound
12/17/1998CA2293480A1 2-aminoalkylaminoquinolines as dopamine d4 ligands
12/17/1998CA2293440A1 3-substituted pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives, and production and use of the same
12/17/1998CA2293439A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998CA2293407A1 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998CA2293350A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
12/17/1998CA2293335A1 9-oxime erythromycin derivatives
12/17/1998CA2293303A1 Tazarotene and uvb phototherapy treatment for psoriasis
12/17/1998CA2292879A1 Composition for prophylaxis and/or treatment of dry eye syndrome comprising vitamin d
12/17/1998CA2292628A1 Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride
12/17/1998CA2292611A1 Estrogen receptor ligands
12/17/1998CA2291653A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
12/17/1998CA2291651A1 Tricyclic pyrrole or pyrazole derivative
12/17/1998CA2291079A1 Method for manufacturing pure guar meal
12/17/1998CA2291055A1 Inhibitors of .beta.-lactamases and uses therefor
12/16/1998EP0884386A1 Sodium channel receptor
12/16/1998EP0884385A1 Intracellular modulators of apoptopic cell death pathways
12/16/1998EP0884330A1 Process for producing pure guar seed flour
12/16/1998EP0884326A2 Antithrombitic compound
12/16/1998EP0884321A1 Ascorbic acid 2-phosphate zinc salt and process for manufacturing the same
12/16/1998EP0884319A2 [1,3]oxazino[3,2-A]indole derivative
12/16/1998EP0884317A2 Active oxygen scavengers containing pterin derivatives
12/16/1998EP0884316A1 Quinazoline-4-one AMPA antagonists
12/16/1998EP0884310A1 Quinazolin-4-one ampa antagonists
12/16/1998EP0884308A2 A method of preparing 16-dehydro vitamin D compounds
12/16/1998EP0884054A2 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist for the treatment of cardiovascular illnesses
12/16/1998EP0884051A1 Cancerous metastasis inhibitors containing uracil derivatives
12/16/1998EP0884050A1 Use of 3,4-dihydroxy-2-hydroxymethylpyrrolidine for the treatment of diabetes
12/16/1998EP0884049A1 Use of an alkylenedioxybenzene derivative for the treatment of circadian rythm sleep disorder
12/16/1998EP0884048A1 Cosmetic and dermatological emulsions containing alkylglucosides and increased electrolyte concentrations
12/16/1998EP0884042A1 Medicament and method of treating an organism with medicaments
12/16/1998EP0883993A1 Antiviral materials
12/16/1998EP0883695A1 Method and composition for hair removal
12/16/1998EP0883688A1 Adapter molecules for targeting viral particles to cells
12/16/1998EP0883681A1 Conjugated linoleic acids for attenuating the allergic response
12/16/1998EP0883628A1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof
12/16/1998EP0883625A1 Novel platelet activation protein
12/16/1998EP0883622A1 Proton pump inhibitor
12/16/1998EP0883621A1 Cephalosporin derivatives and processes for the preparation thereof
12/16/1998EP0883619A1 Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type
12/16/1998EP0883616A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
12/16/1998EP0883609A1 Selective d1 dopamine receptor agonists and partial agonists/antagonists
12/16/1998EP0883608A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids
12/16/1998EP0883606A1 Process for scavenging thiols
12/16/1998EP0883599A1 Aminotetralin derivatives and compositions and method of use thereof
12/16/1998EP0883596A1 Fluorinated propranolol and related methods
12/16/1998EP0883438A1 Antimicrobial compositions
12/16/1998EP0883405A1 Amidino protease inhibitors
12/16/1998EP0883404A1 Combination therapy for osteoporosis
12/16/1998EP0883403A1 Method for treating sexual dysfunctions
12/16/1998EP0883402A1 Novel cycloalkyl substituded imidazoles
12/16/1998EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis
12/16/1998EP0883400A1 Delivery system for localized administration of medicaments to the upper respiratory tract
12/16/1998EP0883398A1 Method of inhibiting photoaging of skin
1 ... 6565 6566 6567 6568 6569 6570 6571 6572 6573 6574 6575 6576 6577 6578 6579 6580 6581 6582 6583 6584 6585 ... 7860